ALK-Abelló A/S

kr 242.80As of Sun 8 Nov 2026, 12:00 UTC
CPH:ALK-BHealthcare
Country Denmark
PE (Fwd) •••
TSR 10Y CAGR 18.26%
Div yield 0.66%
ROE 21.21%
Biotechnology
Beta (5Y) 0.74
PE TTM 39.82
TSR TTM 14.64%
Mkt cap kr 53.87B
ROIC 24.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 255
5.20%
22.45%
Hold 12|9|2|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
2.44
2.70
2.61
2.92
5.67%
14.56%
14.37%
18.54%
Revenuekr B
4.820
4.986
5.043
5.173
5.20%
3.22%
4.29%
4.45%
Peers (US$8.031B)
Cap (US$)
PE
16.87B
19.19x
2.720B
12.41x
2.365B
6.044x
Capital
TTM
5Y
10Y
Leveragex
0.381
(0.911)
(0.817)
EBIT/Intx
1.095
1.575
1.688
Own earn%
(123.87)
43.96
48.50
Sh yield%
48.73
21.18
20.74
Owners
Insiders/Inst%
13.49
30.54
Short interest%
5.61
SBC / revenue%
1.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
27–30
$1 testx
0.2
Incr. ROIC%
13